Study Results

Stay connected

June 2, 2017

Acne drug can be used to treat early MS symptoms

A Canadian clinical trial led by researchers at the University of Calgary’s Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), shows that minocycline – a common acne medication –  can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms. This discovery is significant as it offers a safe and affordable treatment option for those with early onset MS. “This is a spectacular outcome that will positively impact people’s lives worldwide,” said Dr. Sam Weiss, Director of HBI and the new Scientific Director of the CIHR’s Institute of Neurosciences, Mental Health and Addiction.

Date modified: